350 related articles for article (PubMed ID: 1496968)
1. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Hughson MD; Nadasdy T; McCarty GA; Sholer C; Min KW; Silva F
Am J Kidney Dis; 1992 Aug; 20(2):150-8. PubMed ID: 1496968
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy.
Chen W; Liang S; Zuo K; Yang L; Zeng C; Hu W
Clin Rheumatol; 2021 Jul; 40(7):2735-2743. PubMed ID: 33543375
[TBL] [Abstract][Full Text] [Related]
3. Renal involvement in antiphospholipid syndrome.
de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM
Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854
[TBL] [Abstract][Full Text] [Related]
4. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
[TBL] [Abstract][Full Text] [Related]
5. Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival.
Bridoux F; Vrtovsnik F; Noël C; Saunier P; Mougenot B; Lemaitre V; Dracon M; Lelièvre G; Vanhille P
Nephrol Dial Transplant; 1998 Feb; 13(2):298-304. PubMed ID: 9509438
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
7. Catastrophic antiphospholipid syndromes in systemic lupus erythematosus.
Stratta P; Canavese C; Ferrero S; Grill A; Salomone M; Schinco PC; Fusaro E; Montaruli B; Santi S; Piccoli G
Ren Fail; 1999 Jan; 21(1):49-61. PubMed ID: 10048117
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus.
Kotzen ES; Roy S; Jain K
Adv Chronic Kidney Dis; 2019 Sep; 26(5):376-386. PubMed ID: 31733722
[TBL] [Abstract][Full Text] [Related]
9. Lupus glomerulonephritis with thrombotic microangiopathy.
Magil AB; McFadden D; Rae A
Hum Pathol; 1986 Feb; 17(2):192-4. PubMed ID: 3512413
[TBL] [Abstract][Full Text] [Related]
10. The intrarenal vascular lesions associated with primary antiphospholipid syndrome.
Nochy D; Daugas E; Droz D; Beaufils H; Grünfeld JP; Piette JC; Bariety J; Hill G
J Am Soc Nephrol; 1999 Mar; 10(3):507-18. PubMed ID: 10073601
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome.
Hughson MD; McCarty GA; Sholer CM; Brumback RA
Mod Pathol; 1993 Nov; 6(6):644-53. PubMed ID: 8302806
[TBL] [Abstract][Full Text] [Related]
12. Coagulopathy as a complication of kidney biopsies in paediatric systemic lupus erythematosus patients with antiphospholipid syndrome.
Nagata H; Sato M; Ogura M; Yoshikawa T; Yamamoto K; Matsumura S; Kano Y; Saida K; Sako M; Kamei K; Yoshioka T; Ogata K; Ito S; Ishikura K
Nephrology (Carlton); 2018 Jun; 23(6):592-596. PubMed ID: 28976051
[TBL] [Abstract][Full Text] [Related]
13. Identification and treatment of APS renal involvement.
Tektonidou MG
Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
[TBL] [Abstract][Full Text] [Related]
14. Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients.
Jordan N; Chaib A; Sangle S; Tungekar F; Sabharwal T; Abbs I; Khamashta M; D'Cruz D
Arthritis Care Res (Hoboken); 2014 May; 66(5):725-31. PubMed ID: 24127353
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
Tektonidou MG; Sotsiou F; Moutsopoulos HM
J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
[TBL] [Abstract][Full Text] [Related]
16. Is it possible to diagnose primary anti-phospholipid syndrome (PAPS) on the basis of renal thrombotic microangiopathy (PAPS nephropathy) in the absence of other thrombotic process?
Rollino C; Mazzucco G; Boero R; Beltrame G; Quattrocchio G; Ferro M; Milan M; Berruti S; Quarello F
Ren Fail; 2003 Nov; 25(6):1043-9. PubMed ID: 14669864
[TBL] [Abstract][Full Text] [Related]
17. Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy.
Tektonidou MG
Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):131-40. PubMed ID: 19048414
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome.
Hughson MD; McCarty GA; Brumback RA
Hum Pathol; 1995 Jul; 26(7):716-24. PubMed ID: 7628842
[TBL] [Abstract][Full Text] [Related]
19. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis.
Horita S; Zoshima T; Hara S; Koichi M; Hirayama S; Suzuki K; Nakashima A; Kawano M
CEN Case Rep; 2021 Aug; 10(3):409-413. PubMed ID: 33595828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
